Does lowering the blood pressure improve the mood? Quality-of-life results from the hypertension optimal treatment (HOT) study

Blood Pressure

Volumn 6, Issue 6, 1997, Pages 357-364

  Wiklund, Ingela ^a   Halling, Katarina ^a   Rydén Bergsten, Tina ^a   Fletcher, Astrid ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Felodipine; Hypertension; Quality of life; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; STEROID;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031425435     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059709062095     Document Type: Article

References (42)

1. The HOT Study Group. The Hypertension Optimal Treatment Study (The HOT study). Blood Press 1993; 2: 62-8.
2. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension: report of Medical Research Council Working Party on mild to moderate hypertension. Lancet 1981; 2: 539-43.
3. Van Hoof R, Amery A, Fagard R, Staessen J. Quality of life during treatment of hypertensive patients with diuretics. Acta Cardiol 1990; 45: 393-401.
4. Bulpitt CJ, Dollery CT, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J 1976; 38: 121-8.
5. Weiss NS. Relation of high blood pressure to headache, epistaxis, and selected other symptoms. The United States Health Examination survey of Adults. N Engl J Med 1972; 287: 632-3.
6. Bansal S. Sexual dysfunction in hypertensive men. A critical review of the literature. Hypertension 1988; 12: 1-10.
7. Shapiro AP, Miller RE, King HE, Ginchereau EH, Fitzgibbon K. Behavioral consequences of mild hypertension. Hypertension 1982; 4: 355-6.
8. Vanderploeg RD, Goldman H, Kleinman KM. Relationship between systolic and diastolic blood pressure and cognitive functioning in hypertensive subjects: an extension of previous findings. Arch Clin Neuropsychol 1987; 2: 101-9.
9. Hjemdahl P, Wiklund I. Quality of life on antihypertensive drug therapy - scientific end-point or marketing exercise? J Hypertens 1992; 10: 1437-46.
10. Steiner SS, Friedhoff AJ, Wilson BL, Wecker JR, Santo JP. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. J Hum Hypertens 1990; 4: 217-25.
11. Fletcher AE, Bulpitt CJ, Hawkins CM, et al. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens 1990; 8: 463-6.
12. Hill JF, Bulpitt CJ, Fletcher AE. Angiotensin converting enzyme inhibitors and quality of life: the European trial. J Hypertens 1985; 3 (Suppl 2): S91-4.
13. Palmer AJ, Fletcher AE, Rudge PJ, Andrews CD, Callaghan TS, Bulpitt CJ. Quality of life in hypertensives treated with atenolol or captopril: a double-bind crossover trial. J Hypertens 1992; 10: 1409-16.
14. Welzel D, Bräutigam M. Beta-receptor blockade versus Kalzium-Antagonismus. Eine vergleichende Studie über Bopindolol und Nifedipin unter besonderer Berücksichtigung der Lebensqualität. Arzneimittelforschung 1989; 39: 499-503.
15. Frimodt-Moeller J, Poulsen DL, Kornerup HJ, Bech P. Quality of life, side effects and efficacy of lisinopril compared with metoprolol in patients with mild to moderate essential hypertension. J Hum Hypertens 1991; 5: 215-21.
16. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of mild hypertension study. Final results. JAMA 1993; 270: 713-24.
17. Hansson L, for the BBB Study Group. The BBB Study: the effect of intensified antihypertensive treatment on the level of blood pressure, side-effects, morbidity and mortality in "well-treated" hypertensive patients. Blood Pressure 1994; 3: 248-54.
18. Pilgrim JA, Stansfeld S, Marmot M. Low blood pressure, low mood? BMJ 1992; 304: 75-8.
19. Barrett-Connor E, Palinkas LA. Low blood pressure and depression in older men: a population based study. BMJ 1994; 308: 446-9.
20. Goldberg EL, Comstock GW, Graves CG. Psychological factors and blood pressure. Psychol Med 1980; 10: 243-55.
21. Wessely S, Nickson J, Cox B. Symptoms of low blood pressure: a population study. BMJ 1990; 301: 362-5.
22. Rosengren A, Tibblin G, Wilhelmsen L. Low systolic blood pressure and self perceived well being in middle aged men. BMJ 1993; 306: 243-6.
23. Hansson L, Zanchetti A, for the HOT Study Group. The Hypertension Optimal Treatment (HOT) Study - patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Pressure 1994; 3: 322-7.
24. Dupuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq Publishing Inc, 1984: 170-83.
25. Dimenäs E, Dahlöf C, Olofsson B, Wiklund I. An instrument for quantifying subjective symptoms among untreated and treated hypertensives: development and documentation. J CHn Res Pharmacoepidemiol 1990; 4: 205-17
26. Bradly JV. Distribution-Free Statistical Test. Prentice Hall, Inc. London 1968:68-86.
27. Bengtsson C, Edström K, Furunes B, Sigurdsson JA, Tibblin G. Prevalence of subjectively experienced symptoms in a population sample of women with special reference to women with arterial hypertension. Scand J Prim Health Care 1987; 5: 155-62.
28. Bulpitt CJ, Fletcher AE. Quality of life evaluation of anithypertensive drugs. Pharmacoeconomics 1992; 1: 95-102.
29. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996; 31 Suppl 221: 8-13.
30. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657-64.
31. Steiner SS, Friedhoff AJ, Wilson BL, Wecker JR, Santo JP. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol. J Hum Hypertens 1990; 4: 217-25.
32. Fletcher AE, Bulpitt CJ, Chase DM, et al. Quality of life with three antihypertensive treatments: cilazapril, atenolol, nifedipine. Hypertension 1992; 19: 499-507.
33. Bulpitt CJ, Fletcher AE. The measurement of quality of life in hypertensive patients: a practical approach. Br J Clin Pharmacol 1990; 30: 353-64.
34. Chang SW, Fine R, Siegel D, et al. The impact of diuretic therapy on reported sexual function. Arch Intern Med 1991; 151: 2402-8.
35. Wiklund I, Dimenäs E, Partridge S. Effects of felodipine extended release on quality of life - an analysis of four clinical trials. Curr Ther Res 1995; 56: 81-94.
36. Siegrist J, Middeke M, Osterkorn K. Lebensqualität hypertensiver Ärzteunter Hochdrucktherapie. Randomisierte Doppelblindstudie an 237 Ärtzinnen und Ärtzen mit Bluthochendruck. Fortschr Med 1991; 109: 348-52.
37. Wassertheil-Smoller S, Blaufox MD, Oberman A, et al. Effect of antihypertensives on sexual function and quality of life: the TAIM study. Ann Intern Med 1991; 114: 613-20.
38. Herrick AL, Waller PC, Berkin KE, et al. Comparison of enalapril and atenolol in mild to moderate hypertension. Am J Med 1989; 86: 421-6.
39. Dimenäs ES, Wiklund IK, Dahlöf CG, Lindvall KG, Olofsson BK, De Faire UH. Differences in subjective well-being and symptoms of normotensives, borderline hypertensives and hypertensives. J Hypertension 1989; 7: 885-90.
40. Di Tullio M, Alli C, Avanzini F, et al. Prevalence of symptoms generally attributed to hypertension or its treatment: study on blood pressure in elderly outpatients (SPAA). J Hypertension 1988; 6 (Suppl 1): S87-90.
41. Perry HM, Brown RD, Herman TS, Meyer JH, Norton JM, Thurm RH. Improved quality of life with good blood pressure control: a comparison of captopril, propranolol, and methyldopa. Abstracts from the International Symposium on ACE Inhibition, London, 1989, 14-17 February: Abs F071.
42. Dahlöf C, Dimenäs E, Kendall M, Wiklund I. Quality of life in cardiovascular diseases - with special reference to β-blocker treatment. Circulation 1991; 84 (Suppl 6): 108-18.